Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$7.03
-3.96%
Mkt Cap $83.09M
Next Earnings
In 8 daysWed, May 6, 2026
EPS Estimate
-$1.88
1 analysts
Revenue Estimate
$407.60K
Last quarter: beat by +20.92% on EPS, -91.74% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$83.09M
P/E
—
Fwd P/E
32.89
P/S
86.14
Rev TTM
—
EPS TTM
$0.64